TAVR for AR: next steps and future challenges

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abiomed; Abbott Vascular; Medtronic; NuPulse; Teleflex; Terumo Medical Corporation
• Grant Support/Research Contract - Boston Scientific Corporation
• CMO - JenaValve